Skip to main content

Advertisement

SpringerLink
Log in

The value of metabolic imaging in diagnosis and resection of cerebral gliomas

  • Viewpoint
  • Published:

From Nature Clinical Practice Neurology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Law M et al. (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24: 1989–1998

    PubMed  Google Scholar 

  2. McKnight TR et al. (2002) Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 97: 794–802

    Article  Google Scholar 

  3. Langen KJ (2003) Amino acid transport studies in brain tumors. In Molecular Nuclear Medicine—The Challenge of Genomics and Proteomics to Clinical Practice, 477–485 (Eds Feinendegen LE et al.) Heidelberg: Springer-Verlag Berlin

    Google Scholar 

  4. Hamacher K and Coenen HH (2002) Efficient routine production of the 18F-labelled amino acid O-(2-[18F]fluoroethyl)-L-tyrosine. Appl Radiat Isot 57: 853–856

    Article  CAS  Google Scholar 

  5. Pauleit D et al. (2005) O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 128: 678–687

    Article  Google Scholar 

  6. Floeth FW et al. (2005) Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. J Neurosurg 102: 318–327

    Article  Google Scholar 

  7. Popperl G et al. (2004) Value of O-(2-[18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging 31: 1464–1470

    Article  Google Scholar 

  8. Ribom D et al. (2001) Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas. Cancer 92: 1541–1549

    Article  CAS  Google Scholar 

  9. Ribom D et al. (2005) Evaluation of (11)C-methionine as a surrogate endpoint after treatment of grade 2 gliomas. J Neurooncol 71: 325–332

    Article  CAS  Google Scholar 

  10. Stummer W et al. (2003) Fluorescence-guided resections of malignant gliomas—an overview. Acta Neurochir 88 (Suppl): S9–S12

    Google Scholar 

  11. Stummer W et al. (2005) Multicentric Phase III study on fluorescence-guided resection of malignant gliomas with 5-ALA: preliminary results on interim analysis of 270 patients [abstract #24638]. 2005 American Association of Neurosurgery Annual Meeting

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. consultants in neurosurgery at the University of Düsseldorf Department of Neurosurgery, Düsseldorf, Germany

    Frank Willi Floeth & Walter Stummer

Authors
  1. Frank Willi Floeth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Walter Stummer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frank Willi Floeth.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Floeth, F., Stummer, W. The value of metabolic imaging in diagnosis and resection of cerebral gliomas. Nat Rev Neurol 1, 62–63 (2005). https://doi.org/10.1038/ncpneuro0043

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0043

  • Springer Nature Limited

This article is cited by

Search

Navigation